Filing Details
- Accession Number:
- 0001415889-24-027473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-21 20:21:28
- Reporting Period:
- 2024-11-19
- Accepted Time:
- 2024-11-21 20:21:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818331 | Genedx Holdings Corp. | WGS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585017 | Jason Ryan | C/O Genedx Holdings Corp. 333 Ludlow St, North Tower Stamford CT 06902 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-11-19 | 141,356 | $0.00 | 47,000 | No | 4 | G | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-19 | 5,952 | $70.86 | 41,048 | No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-19 | 24,784 | $71.35 | 16,264 | No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-19 | 774 | $72.26 | 15,490 | No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-20 | 9,361 | $68.36 | 6,129 | No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-20 | 1,857 | $69.84 | 4,272 | No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| Class A Common Stock | Disposition | 2024-11-20 | 4,272 | $70.50 | 0 | No | 4 | S | Indirect | By Jason Ryan u/a dtd 11/25/2018 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan Trust u/a dtd 11/25/2018 |
| No | 4 | S | Indirect | By Jason Ryan u/a dtd 11/25/2018 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 141,356 | Indirect | By Jason Ryan 2024 GRAT |
| Class A Common Stock | 130 | Direct |
Footnotes
- On November 19, 2024, the reporting person transferred 141,356 shares of GeneDx Holdings Corp. Class A common stock from the reporting person's indirect holdings to the Jason Ryan 2024 GRAT (the "GRAT") for no consideration. The reporting person is the trustee of the GRAT, and the reporting person is the sole annuitant of the grantor retained annuity trust. The reporting person remains the beneficial owner of the securities held by the grantor retained annuity trust.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.026 to $71.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.04 to $72.0302 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.12 to $72.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $68.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.22 to $70.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.22 to $70.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
